Literature DB >> 8235238

Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea.

I Wilcox1, R R Grunstein, J A Hedner, J Doyle, F L Collins, P J Fletcher, D T Kelly, C E Sullivan.   

Abstract

Ambulatory blood pressure (BP) was measured noninvasively (Oxford Medilog ABP) at 15-minute intervals for 24 hours before and after 8 weeks of treatment with nasal continuous positive airway pressure (nCPAP) in 19 men with obstructive sleep apnea (OSA). We included both normotensive and hypertensive patients, but hypertensives were studied after withdrawal of antihypertensive drugs. Ambulatory BP before and after treatment was compared using patients as their own controls. Treatment with nCPAP was successfully established in 14 of the 19 patients (74%). Blood pressure fell significantly in patients who were successfully treated: 24-hour mean BP (systolic/diastolic) decreased from 141 +/- 18/89 +/- 11 mm Hg to 134 +/- 19/85 +/- 13 mm Hg (p < 0.05). The reduction in 24-hour mean systolic BP occurred during both day and night, but a significant fall in mean diastolic BP was only observed during the day. The mean blood pressure fell in both normotensive and hypertensive patients. Patients who were inadequately treated with nCPAP had no reduction in mean 24-hour BP. Effective treatment of sleep apnea with nCPAP was associated with a significant fall in both systolic and diastolic BP independent of changes in body weight or alcohol consumption, suggesting that sleep apnea was an independent factor contributing to elevated nighttime and daytime BP in these patients.

Entities:  

Mesh:

Year:  1993        PMID: 8235238     DOI: 10.1093/sleep/16.6.539

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  37 in total

Review 1.  Prognosis and sleep disordered breathing in heart failure.

Authors:  I Wilcox; S G McNamara; T Wessendorf; G N Willson; A J Piper; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease.

Authors:  I Wilcox; S G McNamara; F L Collins; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 3.  Sleep apnoea and autonomic function.

Authors:  C W Zwillich
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 4.  CPAP therapy: outcomes and patient use.

Authors:  N J Douglas; H M Engleman
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 5.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

Review 6.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

7.  The interdependence of sleep apnea, excess body weight, and hypertension: A triangular relationship.

Authors:  Claude Lenfant
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

8.  Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model.

Authors:  D Brooks; R L Horner; L F Kozar; C L Render-Teixeira; E A Phillipson
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

9.  Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients.

Authors:  Junaid Malik; Christopher L Drake; David W Hudgel
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

10.  Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation.

Authors:  J L Lattimore; I Wilcox; M Skilton; M Langenfeld; D S Celermajer
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.